1808
S. S. Capracotta, D. L. Comins / Tetrahedron Letters 50 (2009) 1806–1808
Table 4
References and notes
Effect of chlorine substituentsa
1. (a) Noyori, R. Asymmetric Catalysis in Organic Synthesis; Wiley: New York, 1994;
(b) Catalytic Asymmetric Synthesis, 2nd ed., Wiley-VCH, New York, 2000.; (c)
Pfaltz, A. Chimia 2004, 58, 49; (d) Ikariya, T.; Murata, K.; Noyori, R. Org. Biomol.
Chem. 2006, 4, 393.
2. Review: (a) Wagner, F. F.; Comins, D. L. Tetrahedron 2007, 63, 8065; (b)
Ondachi, P. W.; Comins, D. L. Tetrahedron Lett. 2008, 49, 569.
3. (a) Karlin, A. Nat. Rev. Neurosci. 2002, 3, 102; (b) Lloyd, G. K.; Williams, M. J.
Pharmacol. Exp. Ther. 2000, 292, 461; (c) Tonder, J. E.; Olesen, P. H. Curr. Med.
Chem. 2001, 8, 651; (d) Jensen, A. A.; Frolund, B.; Liljefors, T.; Krogsgaard-
Larsen, P. J. Med. Chem. 2005, 48, 4705.
Entry
Catalyst
mol %
Yield (%)
ee (%)
1
2
3
4
5
7a
13
13
14
14
20
20
5
20
5
78
61
91
69
36
79 (R)
95 (R)
92 (R)
63 (R)
60 (R)
a
Reactions were run at 0 °C for 24 h in toluene.
4. (a) Anaya de Parrodi, C.; Juaristi, E. Synlett 2006, 2699; (b) Vicario, J. L.; Badía,
D.; Carillo, L.; Reyes, E.; Etxebarria, J. Curr. Org. Chem. 2005, 9, 219; (c)Transition
Metals for Organic Synthesis; Beller, M., Bolm, C., Eds., 2nd ed.; Wiley VCH:
Weinheim Germany, 2004.
5. Février, F. C.; Smith, E. D.; Comins, D. L. Org. Lett. 2005, 7, 5457.
6. Review: Gros, P.; Fort, Y. Eur. J. Org. Chem. 2002, 2375.
7. Crystallographic data (excluding structure factors) for the structure 5a have
been deposited with the Cambridge Crystallographic Data Center as
supplementary publication numbers CCDC 713132. Copies of these data can
be obtained free of charge on application to CCDC, 12 Union Road, Cambridge,
CB2 1EZ, UK.
were employed in the reaction, a decrease in enantioselectivity oc-
curred. In an attempt to discover a way to bring the selectivity up
for these aldehydes, a few different reaction conditions were tested
but no improvement was observed. Overall, the novel nicotine-
based decafluorocatalyst demonstrates good yields and high
enantioselectivities when employed in the catalytic asymmetric
addition of diethylzinc to aromatic aldehydes.
8. Wagner, F. F.; Comins, D. L. Eur. J. Org. Chem. 2006, 3562.
9. For recent examples and leading references, see: (a) Park, J. K.; Lee, H. G.; Bolm,
C.; Kim, B. M. Chem. Eur. J. 2005, 11, 945; (b) Lin, R.-X.; Chen, C. J. Mol. Catal. A:
Chem. 2006, 243, 89; (c) Milburn, R. R.; Hussain, S. M. S.; Prien, O.; Ahmed, Z.;
Snieckus, V. Org. Lett. 2007, 9, 4403.
Finally, to investigate the effect of the C-6 chlorine substituent
on the nicotine-based catalysts during the asymmetric reaction,
compounds 13 and 14 were synthesized from 12 and 7a as shown
in Scheme 3 and compared to 7a. This comparison was intended to
provide insight as to whether or not the C-4 substituted nicotine-
based catalysts could be modified to enhance enantioselectivity
in the asymmetric reaction by adding or removing chlorine substit-
uents on the pyridine ring. Addition of a chlorine substituent to the
C-5 position of the catalyst, as shown with compound 13, increased
the selectivity from 79% to 95% ee at 20 mol %, but at 5 mol % a
slight decrease in selectivity was observed (Table 4, entries 2 and
3). In contrast, catalyst 14, with no chlorine substituents, effected
a decrease in observed selectivity as compared to ligand 7a (entries
4 and 5). This study showed that it is necessary to have at least one
chlorine substituent on the pyridine portion of the catalyst in order
to maintain adequate enantioselectivity in the asymmetric addi-
tion of organozinc reagents to aldehydes.
Although further study is needed to understand how the sub-
stituents affect the degree of chirality transfer, it appears that a
C-6 electron-withdrawing group may be needed to reduce the ba-
sicity, and thus the coordinating ability, of the pyridyl nitrogen.
In summary, novel chiral amino alcohol catalysts have been
prepared in two to three steps from natural (S)-nicotine.10 The
ability of these catalysts to transfer chirality was determined by
using the asymmetric addition of diethylzinc to aldehydes as a
screen. A high degree of enantioselectivity was obtained in several
examples. The effectiveness of these catalysts in other asymmetric
reactions and the synthesis of other types of ligands from commer-
cially available (S)-nicotine are under study in our laboratories.
10. General procedure for the preparation of the nicotine-derived ligands: To
a
solution of (S)-6-chloronicotine (2, 200 mg, 1.02 mmol) in THF (2 mL) was
added n-BuLi (0.68 mL, 1.12 mmol) at ꢀ78 °C. After 1 h, a solution of the
aldehyde or ketone (1.2 equiv) in toluene (2 mL) kept over molecular sieves
was cannulated into the reaction. The mixture was stirred for 30–60 min at
ꢀ78 or ꢀ42 °C after which it was quenched with aqueous saturated sodium
bicarbonate (2 mL). After warming to room temperature, the organic layer was
separated. The aqueous layer was extracted with methylene chloride
(2 ꢁ 10 mL). The combined organic layers were dried over potassium
carbonate, filtered, and concentrated in vacuo. The crude product was
purified by radial PLC (silica gel).
Spectral data: [5-((2S)-1-Methylpyrrolidin-2-yl)-2-chloro(4-pyridyl)]bis(2,3,4,5,6-
pentafluorophenyl)methan-1-ol (7d). The crude product was purified using
radial PLC (5% TEA/hexanes; then CH2Cl2) to afford 146 mg (51%) of 7d as a
white solid, mp 38–40 °C; ½a D32
ꢂ
ꢀ16.9 (c 1.1, CH2Cl2); IR (thin film) 3380, 2963,
2924, 2856, 1650, 1578, 1524, 1484, 1122, 1005 cmꢀ1
;
1H NMR (400 MHz,
CDCl3) d 12.82 (s, 1H), 8.36 (s, 1H), 6.93 (s, 1H), 3.54–3.49 (m, 1H), 3.35–3.30
(m, 1H), 2.49–2.41 (m, 1H), 2.27 (s, 3H), 2.24–2.17 (m, 1H), 2.13–1.96 (m, 2H),
1.93–1.85 (m, 1H); 13C NMR (75 MHz, CDCl3) d 154.3, 153.2, 152.5, 146.7,
143.4, 142.9, 139.8, 139.7, 136.7, 136.5, 132.6, 125.3, 79.5, 71.4, 56.3, 39.7,
32.7, 22.4; 19F NMR (282 MHz, CDCl3) d ꢀ133.2 (d, J = 18.6 Hz, 2F), ꢀ133.9 (d,
J = 18.6 Hz, 2F), ꢀ149.7 (m, 2F), ꢀ157.4 (m, 4F); HRMS calcd for C23H13ClF10N2O
([M+H]+) 559.0635, found 559.0654.
Bis[5-((2S)-1-methylpyrrolidin-2-yl)-2-chloro-4-pyridyl]methan-1-ol (11). The
crude product was purified using radial PLC (1% TEA/30% EtOAc/hexanes) to
afford 249 mg (74%) of 11 as a white solid, mp 80–82 °C; ½a D31
ꢀ101 (c 0.95,
ꢂ
CH2Cl2); IR (thin film) 3238, 2967, 2876, 2840, 2787, 1582, 1455, 1372, 1146,
1092 cmꢀ1 1H NMR (400 MHz, CDCl3) d 8.92 (s, 1H), 8.54 (s, 1H), 8.24 (s, 1H),
;
7.67 (s, 1H), 6.41 (s, 1H), 6.31 (s, 1H), 3.46–3.42 (m, 1H), 3.38–3.32 (m, 1H),
3.10–3.06 (m, 1H), 2.89–2.85 (m, 1H), 2.51–2.41 (m, 2H), 2.33–2.20 (m, 4H),
2.16–2.03 (m, 3H), 1.98 (s, 3H), 1.92–1.79 (m, 1H), 1.69–1.56 (m, 3H); 13C NMR
(75 MHz, CDCl3) d 154.1, 152.4, 151.6, 151.3, 150.7, 135.1, 133.6, 123.6, 122.7,
69.8, 67.0, 66.3, 57.3, 57.1, 40.7, 40.6, 34.5, 31.9, 24.6, 22.9; HRMS calcd for
C21H26Cl2N4O (M+) 421.1556, found 421.1554.
5-((2S)-1-Methylpyrrolidin-2-yl)-2,3-dichloro(4-pyridyl)diphenylmethan-1-ol (13).
The crude product was purified using radial PLC (1% TEA/2% EtoAc/hexanes;
Acknowledgments
then CH2Cl2) to afford 46 mg (30%) of 13 as a white solid, mp 170–172 °C; ½a D32
ꢂ
ꢀ164.5 (c 1.1, CH2Cl2); IR (thin film) 3321, 3057, 3027, 2957, 2784, 1550, 1489,
This work was supported in part by Targacept, Inc. We thank Dr.
Paul Boyle (NCSU) for X-ray crystallographic analysis of 5a. NMR,
X-ray analysis, and mass spectra were obtained at NCSU instru-
mentation laboratories, which were established by grants from
the North Carolina Biotechnology Center and the National Science
Foundation (Grant CHE-0078253).
1447, 1310, 1219, 1057 cmꢀ1 1H NMR (400 MHz, CDCl3) d 10.19 (s, 1H), 8.30 (s,
;
1H), 7.41–7.31 (m, 5H), 7.26–7.21 (m, 3H), 7.12–7.10 (m, 2H), 3.48–3.43 (m, 1H),
3.12–3.08 (m, 1H), 2.64–2.55 (m, 1H), 2.34–2.28 (m, 1H), 2.26–2.19 (m, 1H),
2.12–2.00 (m, 1H), 1.89–1.83 (m, 1H), 1.64 (s, 3H); 13C NMR (100 MHz, CDCl3) d
157.4, 150.4, 147.4, 143.2, 136.7, 129.0, 128.2, 128.0, 127.9, 127.8, 127.1, 84.8,
73.2, 56.5, 39.4, 34.8, 22.0; HRMS calcd for C23H22Cl2N2O (M+) 413.1181, found
413.1173.